Chlorothiazide Oral Suspension shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Feb 10, 2026 · last update Feb 10, 2026
Manufacturers: Salix Pharmaceuticals, a division of Bausch Health US, LLC
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Diuril, Oral Suspension, 250 mg/5mL (NDC 65649-311-12) | Salix Pharmaceuticals, a division of Bausch Health US, LLC | To Be Discontinued | — | Posted Feb 10, 2026 Updated Feb 10, 2026 Discontinued Feb 10, 2026 |